Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Atosiban, administered at embryo transfer, can improve the implantation rate and the clinical pregnancy rate in patients with repeated implantation failure undergoing IVF-ET (in-vitro fertilization and embryo transfer).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: An Sinh Hospital
• Collaborator: Vietnam National University
• Treatments: Atosiban; Vasotocin

Criteria

Inclusion Criteria:

• had repeated implantation failure

• have at least 1 good quality embryo for transfer

Exclusion Criteria:

• uterine abnormalities that could compromise the implantation process (e.g. fibroids, endometrial polyp, bicornuate uterus, adhesion of uterine cavity)